Category: Jean Luc Taupin

Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation

5/4/2020

Every year, tens of thousands of deaths are due to end-stage heart failure in Europe and in the US combined. Heart transplantation is the ultimate treatment, but its number is dramatically limited due to the shortage of organs in those countries.

In the same time, the chances of survival beyond one year after transplantation have remained unchanged in recent years, despite significant progress in immunosuppressive therapy and patient care.

One of the most common reasons for long-term graft failure and patient death is an accelerated form of coronary artery disease called cardiac allograft vasculopathy. It is a frequent complication that affects up to half of patients within 10 years following heart transplantation. Yet, until now, little has been known about the different evolutive profiles of cardiac allograft vasculopathy and their risk factors.

Paris Transplant Group at the SFT congress 2019

12/2/2019

The members of the Paris Transplant Group are present at the SFT congress which will take place from December 3, 2019 in Bordeaux, France.

Many lectures by the Paris Transplant Group are planned to present the ongoing research to the French transplant community. The presentations will cover:

The latest results of clinical research, including the TRANSFORM study carried out with Novartis,
Research on transplant prognosis for improved patient follow-up, including the iBox algorithm.
Advances made in understanding the mechanisms at work in the event of rejection or unsuccessful transplantation.

This research covers kidney, lung and other transplantation.

Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation

Paris Transplant Group at the SFT congress 2019

Paris Transplant Group

CATEGORIES

ALl

Archives

Research

Partnerships

Paris Transplant Group